Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Other Non-Current Liabilities: 2015-2025

Historic Other Non-Current Liabilities for BIO-TECHNE (TECH) over the last 11 years, with Jun 2025 value amounting to $27.1 million.

  • BIO-TECHNE's Other Non-Current Liabilities rose 20.34% to $23.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.8 million, marking a year-over-year increase of 20.34%. This contributed to the annual value of $27.1 million for FY2025, which is 105.84% up from last year.
  • Latest data reveals that BIO-TECHNE reported Other Non-Current Liabilities of $27.1 million as of FY2025, which was up 105.84% from $13.2 million recorded in FY2024.
  • Over the past 5 years, BIO-TECHNE's Other Non-Current Liabilities peaked at $27.1 million during FY2025, and registered a low of $10.9 million during FY2023.
  • In the last 3 years, BIO-TECHNE's Other Non-Current Liabilities had a median value of $13.2 million in 2024 and averaged $17.1 million.
  • Per our database at Business Quant, BIO-TECHNE's Other Non-Current Liabilities crashed by 51.81% in 2022 and then surged by 105.84% in 2025.
  • BIO-TECHNE's Other Non-Current Liabilities (Yearly) stood at $25.4 million in 2021, then plummeted by 51.81% to $12.2 million in 2022, then declined by 10.79% to $10.9 million in 2023, then grew by 20.50% to $13.2 million in 2024, then spiked by 105.84% to $27.1 million in 2025.